Quest Diagnostics
616 hedge funds and large institutions have $11.5B invested in Quest Diagnostics in 2017 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 215 increasing their positions, 228 reducing their positions, and 74 closing their positions.
2.08% more ownership
Funds ownership: 88.04% → 90.12% (+2.1%)
6% less repeat investments, than reductions
Existing positions increased: 215 | Existing positions reduced: 228
4% less funds holding
Funds holding: 643 → 616 (-27)
14% less call options, than puts
Call options by funds: $39.2M | Put options by funds: $45.5M
14% less capital invested
Capital invested by funds: $13.4B → $11.5B (-$1.87B)
27% less first-time investments, than exits
New positions opened: 54 | Existing positions closed: 74
63% less funds holding in top 10
Funds holding in top 10: 8 → 3 (-5)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APG Asset Management
Amsterdam,
Netherlands
|
+$174M |
| 2 |
Morgan Stanley
New York
|
+$130M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$41.6M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$37.1M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$36.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ninety One (UK)
London,
United Kingdom
|
-$105M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
-$94.9M |
| 3 |
Capital International Investors
Los Angeles,
California
|
-$83.6M |
| 4 |
Bessemer Group
Woodbridge,
New Jersey
|
-$78.8M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$63.7M |
DGX Hedge Fund Activity: Q3 2017 in Review
616 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q3 2017, worth a combined $11.5B — down 14% from $13.4B a quarter earlier.
Sellers outnumbered buyers: 74 funds closed out of DGX and 54 opened new positions — a net loss of 20 holders — while 228 trimmed existing stakes and 215 added.
The largest buyer was APG Asset Management, adding an estimated $174M. The largest seller was Ninety One (UK), cutting an estimated $105M.
- 616 institutional investors held Quest Diagnostics (DGX) as of Q3 2017, down from 643 in Q2 2017.
- Funds reported $11.5B of Quest Diagnostics stock for Q3 2017, down 14% quarter-over-quarter.
- 54 funds opened new Quest Diagnostics positions in Q3 2017 and 74 closed out, a net change of -20 holders.
- The largest Quest Diagnostics buyer in Q3 2017 was APG Asset Management, an estimated $174M added.
- The largest Quest Diagnostics seller in Q3 2017 was Ninety One (UK), an estimated $105M sold.
Based on aggregated 13F filings for Q3 2017.